Crossmark

The validity of cost-effectiveness analyses of tight glycemic control. A systematic survey of economic evaluations of pharmacological interventions in patients with type 2 diabetes

Crossref DOI link: https://doi.org/10.1007/s12020-020-02489-w

Published Online: 2020-09-21

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Barrera, Francisco J. https://orcid.org/0000-0003-4210-0299
Toloza, Freddy JK.

Ponce, Oscar J.

Zuñiga-Hernandez, Jorge A.

Prokop, Larry J. https://orcid.org/0000-0002-7197-7260
Shah, Nilay D.

Guyatt, Gordon

Rodriguez-Gutierrez, Rene

Montori, Victor M. https://orcid.org/0000-0003-0595-2898
License Information

Text and Data Mining valid from 2020-09-21

Version of Record valid from 2020-09-21
More Information

Article History

Received: 11 July 2020

Accepted: 31 August 2020

First Online: 21 September 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below